Pre-feasibility
Government alignment, land and utility studies, biosafety case, scientific advisory board and priority product definition.
COMPUTATIONAL BIOLOGY · BIOLOGICS · GENOMICS · PANDEMIC READINESS
Katral Advanced Biotech AI Lab is a master-planned research and manufacturing programme—not an operating laboratory. The source dossier specifies a UAE flagship campus, an AI and computational-biology core, high-containment research, GMP biologics and an Africa access network.
The programme combines computation, wet-lab research, containment, manufacturing and access strategy so discoveries can move through a controlled translation path.
GPU-enabled molecular design, high-throughput screening and digital-twin research.
Sequencing, bioinformatics, CRISPR engineering, mRNA and synthetic-biology platforms.
Blueprinted BSL-3/4 containment, mutation modelling and rapid candidate generation.
Recombinant insulin, heat-stable formulation research and injectable development.
Pilot-to-commercial bioreactors, purification, fill-finish and lyophilisation.
AI drug discovery, bioinformatics, molecular wet labs, collaboration floors and repeatable 1,000–2,000 sqm lab modules.
Biologic production, insulin fermentation and purification, injectable fill-finish and lyophilisation lines.
Negative-pressure suites, airlocks, HEPA exhaust, decontamination and separated high-risk movement routes.
GPU clusters, secure genomic-data vaults, hybrid-cloud links, dedicated power, UPS and future solar integration.
Water-for-injection, effluent treatment, biohazard waste, central HVAC and redundant utilities.
Residences, visiting faculty facilities, training institute and global conference capability.
Green separation, climate adaptation and capacity reserved for later research or manufacturing modules.
Plug-and-play services and convertible lab blocks enable R&D-to-pilot transitions without redesigning the campus.
AI and bioinformatics prioritise molecules, proteins and disease mechanisms.
Molecular biology and genomics teams test hypotheses under controlled protocols.
Candidate safety, mechanism and manufacturability are assessed.
Ethics, regulators and partner institutions govern human-study progression.
Qualified processes transfer candidates into pilot and commercial manufacturing.
Regional facilities, government procurement and local workforce development extend availability.
Government alignment, land and utility studies, biosafety case, scientific advisory board and priority product definition.
EPC and specialist lab design, regulatory pathway, equipment validation, workforce plan and phaseable capital schedule.
Construction qualification, facility certification, biosafety verification, quality systems and staged operational authorisation.
Target partners include government science authorities, GMP and biosafety designers, hospital research networks, regulators, manufacturing specialists and long-horizon capital.
Explore privacy-preserving provenance for models, genomic proofs and orbital data custody.
Trust & orbital vaults →